Back to search
Pulmonary Mass
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Mass trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Mass trials you may qualify forPatients with pulmonary arterial hypertension (PAH) are at increased risk of muscle loss and decreased physical activity. This study will aim to (1) understand…
This study will examine the different types of proteins present in the lungs of patients with pneumonia to explore the causes of different types of the disease.…
Lung cancer (LC) is usually diagnosed in advanced stages and continues to be the leading cause of cancer related deaths worldwide. Cancer cachexia are frequent…
GALENOS 1 is a prospective observational study designed to explore longitudinal changes in nutritional status and body composition in patients with head and nec…
This is a double-blind, randomized controlled study evaluating the efficacy and safety of HGXJT in combination with ICI-based standard treatment in lung cancer…
A large amount of patients with COPD suffer from muscle dysfunction characterized by losses of muscle mass and strength. Studies have shown an association betwe…
The pathogenicity of Achromobacter bacteria is not yet well established, but studies show a decline in respiratory function and an increase in mortality associa…
This trial studies the side effects of single fraction stereotactic body radiation therapy after surgery in treating patients with non-small cell lung cancer. S…